Xenon Pharmaceuticals Inc (XENE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 12-2014 | 12-2013 | 12-2012 | 12-2011 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -15,752 | 13,018 | 12,032 | -4,301 | -11,992 |
| Depreciation Amortization | 1,038 | 738 | 705 | 786 | 1,132 |
| Accounts receivable | -107 | 209 | -76 | 11,230 | -11,008 |
| Other Working Capital | -14,020 | -14,256 | -16,675 | 47,418 | -3,266 |
| Other Operating Activity | 10,738 | 557 | 692 | -9,560 | 11,445 |
| Operating Cash Flow | $-18,103 | $266 | $-3,322 | $45,573 | $-13,689 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 10,745 | -1,715 | -11,326 | 1,010 | 14,179 |
| PPE Investments | -551 | -1,529 | -146 | -519 | -280 |
| Other Investing Activity | 0 | 0 | 0 | 0 | -10 |
| Investing Cash Flow | $10,194 | $-3,244 | $-11,472 | $491 | $13,889 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | N/A | N/A | -1,701 | N/A | N/A |
| Common Stock Issued | 278 | 42,657 | 49 | N/A | 2 |
| Other Financing Activity | 0 | -1,533 | -2,739 | 0 | 0 |
| Financing Cash Flow | $278 | $41,124 | $-4,391 | $N/A | $2 |
| Exchange Rate Effect | -5,744 | -4,070 | -3,027 | 170 | -314 |
| Beginning Cash Position | 72,026 | 37,950 | 60,162 | 13,928 | 14,040 |
| End Cash Position | 58,651 | 72,026 | 37,950 | 60,162 | 13,928 |
| Net Cash Flow | $-13,375 | $34,076 | $-22,212 | $46,234 | $-112 |
| Free Cash Flow | |||||
| Operating Cash Flow | -18,103 | 266 | -3,322 | 45,573 | -13,689 |
| Capital Expenditure | -551 | -1,529 | -156 | -526 | -290 |
| Free Cash Flow | -18,654 | -1,263 | -3,478 | 45,047 | -13,979 |